Transactions
Affichage de - 18 éléments sur 952
-
US$92m
Candel Therapeutics
Joint Bookrunner (CMPO)
-
US$75m
Quantum-SI
Sole Agent (At-the-Market Offering)
-
Neuronetics
Financial Advisor to Neuronetics on its Merger with Greenbrook TMS
-
UCB
Advisor to UCB on the Sale of the Rights of Nootropil® and Atarax® Products to Advanz Pharma
-
Telemos Capital
Exclusive Financial Advisor (Buy side)
-
US$46m
TELA Bio
Joint Bookrunner (Follow-On Offering)
-
US$207m
CeriBell
Co-Manager (IPO)
-
VisiQuate
Financial Advisor to VisiQuate on its Acquisition by Accel-KKR
-
Sam Brown
Financial Advisor to Sam Brown Inc. on its Sale to Blue Matter
